Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-10

Clinical Trial Update: Liposome Bupivacaine for WRIST Blocks [Phase 2]

View source ↗

Summary

Phase 2 trial update for liposome bupivacaine used in wrist blocks in Dupuytren's Contracture of the Hand (Viking's Disease); study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liposome bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Catherine Vandepitte, M.D. | Conditions: Dupuytren's Contracture of the Hand (Viking's Disease) | Phase 2 | Status: COMPLETED